The role of inflammation in early and late venous thrombosis: Are there clinical implications?
暂无分享,去创建一个
[1] A. Schmaier,et al. D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis , 2004, Thrombosis and Haemostasis.
[2] M. Pfeffer,et al. C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.
[3] L. Jørgensen,et al. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome , 2005, Thrombosis and Haemostasis.
[4] A. Kastrati,et al. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction , 2004, Thrombosis and Haemostasis.
[5] T. Wakefield,et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. , 2005, Blood.
[6] A. Schmaier,et al. D-Dimer, P-Selectin, and Microparticles: Novel Markers To Predict Deep Venous Thrombosis. , 2004 .
[7] T. Wakefield,et al. Deep vein thrombosis resolution is not accelerated with increased neovascularization. , 2004, Journal of vascular surgery.
[8] E. Papalambros,et al. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment. , 2004, Journal of the American College of Surgeons.
[9] P. Prandoni. Toward the Simplification of Antithrombotic Treatment of Venous Thromboembolism , 2004, Annals of Internal Medicine.
[10] T. Wakefield,et al. Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[11] A. Mansfield,et al. Venous Claudication in Iliofemoral Thrombosis: Long-term Effects on Venous Hemodynamics, Clinical Status, and Quality of Life , 2004 .
[12] H. Messmore,et al. Mechanisms of Venous and Arterial Thrombosis in Heparin-Induced Thrombocytopenia , 2000, Journal of Thrombosis and Thrombolysis.
[13] M. Prins,et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose infractionated heparin for venous thromboembolism [Cochrane review] , 2004 .
[14] J. Caprini,et al. A Guide to Venous Thromboembolism Risk Factor Assessment , 2004, Journal of Thrombosis and Thrombolysis.
[15] C. Hack,et al. Human cell‐derived microparticles promote thrombus formation in vivo in a tissue factor‐dependent manner , 2003, Journal of thrombosis and haemostasis : JTH.
[16] D. Wagner,et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. , 2003, Journal of vascular surgery.
[17] T. Wakefield,et al. Neutropenia impairs venous thrombosis resolution in the rat. , 2003, Journal of vascular surgery.
[18] R. Bucek,et al. The role of soluble cell adhesion molecules in patients with suspected deep vein thrombosis , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[19] T. Wakefield,et al. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. , 2003, Surgery.
[20] A. Hafezi-Moghadam,et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.
[21] R. White,et al. The epidemiology of venous thromboembolism. , 2003, Circulation.
[22] J. Chou,et al. Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.
[23] R. Visse,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[24] L. Greenfield,et al. Factors associated with recurrent venous thromboembolism in patients with malignant disease. , 2003, Journal of vascular surgery.
[25] J. Fallon,et al. Inhibition of tissue factor limits the growth of venous thrombus in the rabbit , 2003, Journal of thrombosis and haemostasis : JTH.
[26] Alberto Smith,et al. Failure of Thrombus to Resolve in Urokinase-Type Plasminogen Activator Gene-Knockout Mice: Rescue by Normal Bone Marrow-Derived Cells , 2003, Circulation.
[27] Alberto Smith,et al. Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation , 2003, Thrombosis and Haemostasis.
[28] J. Fowlkes,et al. Decrease in fibrin content of venous thrombi in selectin-deficient mice. , 2003, The Journal of surgical research.
[29] R. Strieter,et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. , 2002, The Journal of surgical research.
[30] L. Greenfield,et al. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. , 2002, Journal of vascular surgery.
[31] F. Dignat-George,et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. , 2002, Blood.
[32] Chung-Ren Lin,et al. Early diagnosis of deep vein thrombosis in female patients who undergo total knee arthroplasty with measurement of P-selectin activation. , 2002, Journal of vascular surgery.
[33] L. Greenfield,et al. New and Effective Treatment of Experimentally Induced Venous Thrombosis with Anti-inflammatory rPSGL-Ig , 2002, Thrombosis and Haemostasis.
[34] T. Shimazu,et al. Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. , 2002, The Journal of trauma.
[35] Z. Galis,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[36] S. Rennard,et al. Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. , 2001, The Journal of allergy and clinical immunology.
[37] F. Picard,et al. Flow Cytometry Detection of Platelet Procoagulant Activity and Microparticles in Patients with Unstable Angina Treated by Percutaneous Coronary Angioplasty and Stent Implantation , 2001, Thrombosis and Haemostasis.
[38] J. Fowlkes,et al. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. , 2001, The Journal of surgical research.
[39] L. Melton,et al. The Epidemiology of Venous Thromboembolism in the Community , 2001, Thrombosis and Haemostasis.
[40] T. Shimazu,et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. , 2001, The Journal of trauma.
[41] B. Bennett,et al. Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u‐PA‐dependent mechanism , 2001, British journal of haematology.
[42] C. Hack,et al. Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.
[43] M. Goebeler,et al. Chemokines in cutaneous wound healing , 2001, Journal of leukocyte biology.
[44] L. Greenfield,et al. P-Selectin Antagonism Causes Dose-dependent Venous Thrombosis Inhibition , 2001, Thrombosis and Haemostasis.
[45] D. Wagner,et al. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Koksch,et al. P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[47] Z. Stelmasiak,et al. [Blood platelet activation markers in patients with acute cerebral infarction during the earliest stage of the disease--evaluation using flow cytometry methods]. , 2000, Neurologia i neurochirurgia polska.
[48] J. Badimón,et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. , 2000, Blood.
[49] K. Schrör,et al. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. , 2000, Thrombosis research.
[50] J. Hartwig,et al. P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Expressed on Platelets and Can Mediate Platelet–Endothelial Interactions in Vivo , 2000, The Journal of experimental medicine.
[51] R. Strieter,et al. Viral IL-10 Gene Transfer Decreases Inflammation and Cell Adhesion Molecule Expression in a Rat Model of Venous Thrombosis1 2 , 2000, The Journal of Immunology.
[52] M. U. Nollert,et al. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. , 2000, Blood.
[53] L. Greenfield,et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. , 2000, Journal of vascular surgery.
[54] F. Rosendaal,et al. Increased soluble P‐selectin levels following deep venous thrombosis: cause or effect? , 2000, British journal of haematology.
[55] K. Burnand,et al. Changes in the Levels of Soluble Adhesion Molecules and Coagulation Factors in Patients with Deep Vein Thrombosis , 1999, Thrombosis and Haemostasis.
[56] M. Waltham,et al. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. , 1999, Journal of vascular surgery.
[57] M. Mesri,et al. Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[58] K. Peterson,et al. Acute pulmonary thromboembolism: has its evolution been redefined? , 1999, Circulation.
[59] M. Prins,et al. Deep-vein thrombosis , 1999, The Lancet.
[60] A. M. Lefer,et al. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. , 1999, Cardiovascular research.
[61] G. Raskob,et al. The Economic Impact of Treating Deep Vein Thrombosis with Low-Molecular-Weight Heparin: Outcome of Therapy and Health Economy Aspects , 1998, Pathophysiology of Haemostasis and Thrombosis.
[62] M. Mesri,et al. Endothelial cell activation by leukocyte microparticles. , 1998, Journal of immunology.
[63] A. M. Lefer,et al. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. , 1998, Circulation.
[64] L. Greenfield,et al. IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. , 1998, Journal of immunology.
[65] S. Werner,et al. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. , 1998, Experimental cell research.
[66] K. See-Tho,et al. Thrombosis with outflow obstruction delays thrombolysis and results in chronic wall thickening of rat veins. , 1998, Journal of vascular surgery.
[67] G. FitzGerald,et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. , 1998, The Journal of clinical investigation.
[68] J. Douketis,et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. , 1998, JAMA.
[69] S. Kunkel,et al. Novel roles for chemokines and fibroblasts in interstitial fibrosis. , 1998, Kidney international.
[70] R. Cummings,et al. Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.
[71] K. Nadeau,et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. , 1997, The Journal of clinical investigation.
[72] J. Hirsh,et al. Management of anticoagulation before and after elective surgery. , 1997, The New England journal of medicine.
[73] L. Greenfield,et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. , 1997, Journal of vascular surgery.
[74] M. Moia,et al. Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial , 1997, Thrombosis and Haemostasis.
[75] K S Sakariassen,et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[76] Paolo Prandoni,et al. The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.
[77] L. Horstman,et al. Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses. , 1995, Thrombosis research.
[78] P. Daly,et al. Elevated platelet-derived microparticle levels during unstable angina. , 1995, The Canadian journal of cardiology.
[79] L. Wakefield,et al. Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin , 1995, Nature Medicine.
[80] L. Greenfield,et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[81] M. Sakon,et al. Quantitative determination of circulating platelet microparticles by flow cytometry. , 1994, International journal of cardiology.
[82] G. Stewart,et al. Neutrophils and deep venous thrombosis. , 1993, Haemostasis.
[83] C. Benjamin,et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets , 1992, Nature.
[84] P. Walker,et al. A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Anderson FA, Wheeler HB, Goldberg RJ, et al. Arch Intern Med 1991;151:933-8 , 1992 .
[85] D. Hosmer,et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.
[86] J. Hirsh. Drug therapy : heparin , 1991 .
[87] S. Weiss. Tissue destruction by neutrophils. , 1989, The New England journal of medicine.
[88] U. Albrechtsson,et al. NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS , 1985, The Lancet.
[89] F. Grinnell. Fibronectin and wound healing , 1984, Journal of cellular biochemistry.
[90] M Gent,et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. , 1979, The New England journal of medicine.
[91] C. Bacon,et al. SUCCESSFUL PREGNANCY IN ACUTE LEUKÆMIA , 1975, The Lancet.
[92] J. Keller,et al. Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study , 1973, Circulation.